Department of Biochemistry, Genetics and Microbiology at the University of Pretoria, Pretoria, South Africa.
Department of Anatomy at the University of Pretoria, Pretoria, South Africa.
J Ethnopharmacol. 2023 Jun 12;309:116377. doi: 10.1016/j.jep.2023.116377. Epub 2023 Mar 11.
Tea (Camellia sinensis) has been consumed for centuries as traditional medicine for various diseases, including diabetes. The mechanism of action of many traditional medicines, including tea, often requires elucidation. Purple tea is a natural mutant of Camellia sinensis, grown in China and Kenya, and is rich in anthocyanins and ellagitannins.
Here we aimed to determine whether commercial green and purple teas are a source of ellagitannins and whether green and purple teas, purple tea ellagitannins and their metabolites urolithins have antidiabetic activity.
Targeted UPLC-MS/MS was employed to quantify the ellagitannins corilagin, strictinin and tellimagrandin I, in commercial teas. The inhibitory effect of commercial green and purple teas and purple tea ellagitannins was evaluated on α-glucosidase and α-amylase. The bioavailable urolithins were then investigated for additional antidiabetic effects, by evaluating their effect on cellular glucose uptake and lipid accumulation.
Corilagin, strictinin and tellimagrandin I (ellagitannins) were identified as potent inhibitors of α-amylase and α-glucosidase, with K values significantly lower (p < 0.05) than acarbose. Commercial green-purple teas were identified as ellagitannin sources, with especially high concentrations of corilagin. These commercial purple teas, containing ellagitannins, were identified as potent α-glucosidase inhibitors with IC values significantly lower (p < 0.05) than green teas and acarbose. Urolithin A and urolithin B were as effective (p> 0.05) as metformin in increasing glucose uptake in adipocytes, muscle cells and hepatocytes. In addition, similar (p > 0.05) to metformin, both urolithin A and urolithin B reduced lipid accumulation in adipocytes and hepatocytes.
This study identified green-purple teas as an affordable widely available natural source with antidiabetic properties. Furthermore, additional antidiabetic effects of purple tea ellagitannins (corilagin, strictinin and tellimagrandin I) and urolithins were identified.
茶(茶树)已被用作传统医学的药用植物,用于治疗各种疾病,包括糖尿病。许多传统药物(包括茶)的作用机制通常需要阐明。紫茶是一种天然的茶树突变体,在中国和肯尼亚种植,富含花青素和鞣花单宁。
本研究旨在确定商业绿茶和紫茶是否是鞣花单宁的来源,以及绿茶和紫茶、紫茶鞣花单宁及其代谢产物尿石素是否具有抗糖尿病活性。
采用靶向 UPLC-MS/MS 定量分析商业茶中的鞣花单宁柯里拉京、鞣花丹宁和 Tellimagrandin I。评估商业绿茶和紫茶以及紫茶鞣花单宁对α-葡萄糖苷酶和α-淀粉酶的抑制作用。然后通过评估其对细胞葡萄糖摄取和脂质积累的影响,研究生物可利用的尿石素的额外抗糖尿病作用。
柯里拉京、鞣花丹宁和 Tellimagrandin I(鞣花单宁)被鉴定为α-淀粉酶和α-葡萄糖苷酶的有效抑制剂,其 K 值明显低于(p<0.05)阿卡波糖。商业绿-紫茶被鉴定为鞣花单宁的来源,其中柯里拉京的浓度特别高。这些含有鞣花单宁的商业紫茶被鉴定为强效的α-葡萄糖苷酶抑制剂,其 IC 值明显低于(p<0.05)绿茶和阿卡波糖。尿石素 A 和尿石素 B 在增加脂肪细胞、肌肉细胞和肝细胞的葡萄糖摄取方面与二甲双胍同样有效(p>0.05)。此外,与二甲双胍相似(p>0.05),尿石素 A 和尿石素 B 均能减少脂肪细胞和肝细胞中的脂质积累。
本研究鉴定了绿-紫茶是一种具有抗糖尿病特性的、价格合理、广泛易得的天然来源。此外,还发现了紫茶鞣花单宁(柯里拉京、鞣花丹宁和 Tellimagrandin I)和尿石素的额外抗糖尿病作用。